List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 87 studies with search of:   "Leiomyosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Interventions: Drug: Letrozole;   Other: Standard of Care
2 Recruiting Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
3 Active, not recruiting A Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Interventions: Drug: Yondelis;   Drug: Yondelis
4 Active, not recruiting Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Conditions: Uterine Leiomyosarcoma;   Uterine Cancer
Intervention: Drug: Docetaxel plus Gemcitabine
5 Recruiting Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
Conditions: Mesenchymal Tumor;   Carcinosarcoma;   Leiomyosarcoma
Interventions: Drug: PegLiposomal Doxorubicin;   Drug: Carboplatin
6 Recruiting A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
Conditions: Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET);   Rhabdomyosarcoma;   Leiomyosarcoma;   Adipocytic Sarcoma;   Synovial Sarcoma
Intervention: Biological: IMC-A12
7 Active, not recruiting Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Conditions: Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: docetaxel;   Drug: filgrastim;   Drug: gemcitabine hydrochloride
8 Active, not recruiting Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Condition: Sarcoma
Interventions: Drug: temozolomide;   Drug: thalidomide
9 Recruiting Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Condition: Sarcoma
Interventions: Drug: docetaxel;   Drug: gemcitabine hydrochloride
10 Active, not recruiting Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Condition: Sarcoma
Interventions: Drug: docetaxel;   Drug: filgrastim;   Drug: gemcitabine hydrochloride;   Drug: pegfilgrastim
11 Active, not recruiting Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Condition: Sarcoma
Intervention: Drug: sunitinib malate
12 Recruiting Bevacizumab and Radiation Therapy for Sarcomas
Conditions: Soft Tissue Sarcoma;   Fibrous Histiocytoma;   Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma;   Synovial Sarcoma
Interventions: Drug: Bevacizumab;   Procedure: Radiation Therapy
13 Active, not recruiting GW786034 In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
Conditions: Sarcoma;   Leiomyosarcoma;   Adipocytic Tumors;   Synovial Sarcoma
Intervention: Drug: GW786034
14 Recruiting Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
Conditions: Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma
Intervention: Drug: Sunitinib Malate (SUTENT, SU011248)
15 Active, not recruiting Study of AP23573, an mTOR Inhibitor, in Patients With Advanced Sarcoma
Conditions: Leiomyosarcoma;   Liposarcoma;   Osteosarcoma;   Sarcoma, Soft Tissue;   Metastases
Intervention: Drug: AP23573
16 Recruiting Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
Conditions: Osteosarcoma;   Ewing Sarcoma Family Tumors;   Malignant Fibrous Histiocytoma;   Sarcoma, Synovial;   Fibrosarcoma;   Leiomyosarcoma
Intervention: Biological: REOLYSIN
17 Suspended Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
Condition: Sarcoma
Intervention: Drug: trabectedin
18 Withdrawn Ifosfamide in Treating Patients With Meningeal Tumors
Conditions: Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Rhabdomyosarcoma;   Adult Malignant Meningioma;   Adult Brain Malignant Hemangiopericytoma
Interventions: Drug: ifosfamide;   Procedure: chemotherapy
19 Completed Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
Condition: Cancer
Intervention: Drug: ARQ 501
20 Completed Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: gemcitabine hydrochloride

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services